◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

ホーム全銘柄 › RMD · English version

ResMed Inc (RMD)

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Health Care · ウォール街(米国) · 最終更新: 2026-08-16

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.

主要指標

インタラクティブチャートと全財務諸表を見る → バリュエーションモデル(DCF)→

年次損益計算書

損益計算書TTM → 2026-03-312025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
売上高合計$5.5B$5.1B$4.7B$4.2B$3.6B$3.2B$3.0B$2.6B$2.3B$2.1B$1.8B$1.7B$1.6B$1.5B$1.4B$1.2B$1.1B$921M$835M$716M$607M
売上総利益$3.4B$3.1B$2.7B$2.4B$2.0B$1.8B$1.7B$1.5B$1.4B$1.2B$1.1B$1.0B$990M$941M$821M$741M$655M$554M$494M$384M$377M
売上総利益率 %61.7%59.4%56.7%55.8%56.6%57.5%58.1%59.0%58.2%58.1%58.0%60.2%63.6%62.1%60.0%59.6%60.0%60.2%59.1%53.7%62.1%
営業利益(EBIT)$1.9B$1.7B$1.3B$1.1B$1.0B$904M$810M$579M$542M$426M$429M$409M$405M$355M$294M$267M$240M$190M$143M$90M$131M
営業利益率 %34.3%32.8%28.2%26.8%28.0%28.3%27.4%22.2%23.2%20.6%23.3%24.4%26.1%23.4%21.5%21.5%22.0%20.7%17.1%12.6%21.6%
当期純利益$1.5B$1.4B$1.0B$898M$779M$475M$622M$405M$316M$342M$352M$353M$345M$307M$255M$227M$190M$146M$110M$66M$88M
純利益率 %27.4%27.2%21.8%21.2%21.8%14.8%21.0%15.5%13.5%16.6%19.2%21.0%22.2%20.3%18.6%18.3%17.4%15.9%13.2%9.3%14.5%
EBITDA$2.2B$1.9B$1.5B$1.4B$1.2B$1.1B$990M$706M$680M$569M$541M$482M$485M$470M$423M$374M$322M$190M$205M$90M$174M
1株当たり利益(EPS)$10.33$9.51$6.92$6.09$5.30$3.24$4.27$2.80$2.19$2.40$2.49$2.47$2.39$2.10$1.71$1.44$1.23$0.95$0.70$0.42$0.57
発行済株式数(百万株)147M147M148M147M147M146M146M144M144M142M142M143M144M146M149M157M155M154M157M157M154M

出典: 企業の公開資料(SEC)。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は RMD のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/RMD

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.